A
AtheroMed
AtheroMed is engaged in developing the peripheral atherectomy catheter system to enhance the treatment of below the knee disease
About AtheroMed
AtheroMed Inc. specializes in developing innovative medical devices aimed at treating peripheral artery disease (PAD), a condition characterized by narrowed arteries reducing blood flow to the limbs. The company's flagship product, the Phoenix Atherectomy System, is designed to remove plaque from blood vessels, thereby improving blood flow and reducing the risk of complications such as limb amputation. AtheroMed serves healthcare providers, including hospitals and specialized clinics, operating primarily in the medical device market. The business model revolves around the sale and distribution of its proprietary devices, generating revenue through direct sales and partnerships with medical institutions. The company leverages advanced technology to offer effective and minimally invasive solutions, positioning itself as a leader in the PAD treatment space.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2006
- Headquarters
- Menlo Park, United States
- Open positions
- None listed
- Dealroom signal
- 18.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | May 2014 | $117M | $117M | Volcano Corporation | — |
| DEBTDebt | Dec 2013 | $4.3M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for AtheroMed is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later3 investors entered at this stage
Canaan
Kaiser Permanente Ventures
The Vertical Group
Other known investors1 additional known investor
Volcano Corporation
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about AtheroMed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AtheroMed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.